Isabelle de Cremoux
Director/Board Member presso MAAT PHARMA
Profilo
Isabelle de Cremoux is currently the CEO & Managing Partner at Seventure Partners SA since 2014.
She is also the Director at Enterome SA since 2008, YSOPIA Biosciences SA since 2015, and Maat Pharma SA since 2014.
Additionally, she holds director positions at TargEDys SA, A-Mansia Biotech SA (Belgium), LiMM Therapeutics SA, and Iome Bio SA. Ms. de Cremoux is also the Managing Partner at Ms. de Cremoux SAS and Health for Life Management.
In her former roles, Ms. de Cremoux served as an Independent Director at Naturex SA. She was the Director of Business Development at Laboratoires Fournier SAS from 1998 to 2009.
Ms. de Cremoux also held director positions at MERISTEM Therapeutics SA, Vivostat A, Fluxome Sciences A, Biophytis SA, Polaris SA, Nutrionix SA. She worked as a Principal at Arthur Andersen LLP and Pfizer, Inc.Ms. de Cremoux completed her undergraduate degree at École Centrale Paris.
Posizioni attive di Isabelle de Cremoux
| Società | Posizione | Inizio |
|---|---|---|
| MAAT PHARMA | Director/Board Member | 01/01/2014 |
Seventure Partners SA
 Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Chief Executive Officer | 01/01/2014 |
A-Mansia Biotech SA (Belgium)
 A-Mansia Biotech SA (Belgium) Miscellaneous Commercial ServicesCommercial Services A-Mansia Biotech provides business services. The company was founded on October 11, 2016 and is headquartered in Ottignies-Louvain-la-Neuve, Belgium. | Director/Board Member | - |
LiMM Therapeutics SA
 LiMM Therapeutics SA Financial ConglomeratesFinance LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France. | Director/Board Member | - |
TargEDys SA
 TargEDys SA BiotechnologyHealth Technology TargEDys SA develops microbiome-based solutions for appetite regulation. It provides humanity with easy means of regulating their eating behaviors for the third millennium. The company was founded by Pierre Dechelotte and Gregory Lambert 2011 and is headquartered in Paris, France. | Director/Board Member | - |
YSOPIA Biosciences SA
 YSOPIA Biosciences SA BiotechnologyHealth Technology LNC Therapeutics SA operates as a research and development company that designs and develops medical food formulas. It's develop therapeutic solutions for metabolic and cardiometabolic disorders. The firm also designs and develops formulas for obesity and pre-diabetes sickness. Its products include Stablor, Bariamed, and Fertimed. It encompass serious game, patient community, and support tools: BariaSpoon and BariaFork. The company was founded by Jérôme Théron and Claude Vincent on October 29, 2010 and is headquartered in Bordeaux, France. | Director/Board Member | 10/03/2015 |
Enterome SA
 Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France. | Director/Board Member | 01/01/2008 |
Iome Bio SA
 Iome Bio SA Pharmaceuticals: OtherHealth Technology Iome Bio SA is a French company that provides drug discovery services using microbiome based mechanisms. The company is based in Colmar, France. Katharine Holland has been the CEO of the company since 2021. | Director/Board Member | - |
Precedenti posizioni note di Isabelle de Cremoux
| Società | Posizione | Fine |
|---|---|---|
Seventure Partners SA
Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Director of Investments | 01/01/2014 |
| ░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formazione di Isabelle de Cremoux
| École Centrale Paris | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| MAAT PHARMA | Health Technology |
| BIOPHYTIS S.A. | Health Technology |
| Aziende private | 15 |
|---|---|
Naturex SA
 Naturex SA Food: Specialty/CandyConsumer Non-Durables Naturex SA engages in the manufacture, marketing and distribution of natural ingredients for the food, pharmaceutical and cosmetic industries. The firm's portfolio includes colors, antioxidants, specialty fruits and vegetables, phytoactives, and numerous other plant-based natural ingredients, designed to help its customers. The company was founded by Jacques Dikansky and Thierry Patrick Lambert on January 16, 1992 and is headquartered in Avignon, France. | Consumer Non-Durables |
Laboratoires Fournier SAS
 Laboratoires Fournier SAS Pharmaceuticals: MajorHealth Technology Laboratoires Fournier SAS manufactures pharmaceutical preparations. The company was founded on July 10, 2007 and is headquartered in Rungis, France. | Health Technology |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Commercial Services |
MERISTEM Therapeutics SA
 MERISTEM Therapeutics SA BiotechnologyHealth Technology MERISTEM Therapeutics SA specializes in research and development of therapeutic proteins using plant biotechnology. The firm extracts proteins from plants and seeds and uses them to double as human hemoglobin and antibodies. Its research shows the extracted proteins can assist with the regression of lung, pancreatic and breast cancer. MERISTEM Therapeutics was founded in 1997 and is headquartered in Clermont-Ferrand, France. | Health Technology |
Seventure Partners SA
Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Finance |
| Pfizer, Inc. /Angers & Val-de-Reuil Pharmaceutical Operations | Health Technology |
Fluxome Sciences A/S
 Fluxome Sciences A/S BiotechnologyHealth Technology Fluxome, a Copenhagen-based Danish company, is a recognized leader in the field of industrial biotechnology. Fluxome uses its proprietary, cutting-edge microbial metabolic engineering technology platform to build highly efficient cell factories for the production of a broad range of commercially important nutraceutical ingredients. Fluxome's technology allows the company to rapidly develop and commercialize high purity, natural products manufactured using cost-effective bioprocesses. | Health Technology |
Enterome SA
Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France. | Health Technology |
Vivostat A/S
 Vivostat A/S Medical SpecialtiesHealth Technology Vivostat A/S provides cardiac, thoracic and orthopaedic surgery medical devices. It offers vivostat system, an automated system for the on-site preparation and application of patient-derived fibrin sealant or platelet rich fibrin. Its products include Vivostat autologous fibrin sealant for various settings in surgical areas, transfusion centers, or blood banks and Vivostat platelet rich fibrin, which utilizes the patient's own blood to derive either a surgical sealant to prevent and stop bleedings, or a gel with a high concentration of growth factors that stimulates the healing of chronic wounds, as well as provides application devices. The compnay was founded in 2001 by Tom Bjerg Lauritzen and Niels Hvid and is headquartered in Alleroed, Denmark. | Health Technology |
YSOPIA Biosciences SA
YSOPIA Biosciences SA BiotechnologyHealth Technology LNC Therapeutics SA operates as a research and development company that designs and develops medical food formulas. It's develop therapeutic solutions for metabolic and cardiometabolic disorders. The firm also designs and develops formulas for obesity and pre-diabetes sickness. Its products include Stablor, Bariamed, and Fertimed. It encompass serious game, patient community, and support tools: BariaSpoon and BariaFork. The company was founded by Jérôme Théron and Claude Vincent on October 29, 2010 and is headquartered in Bordeaux, France. | Health Technology |
TargEDys SA
TargEDys SA BiotechnologyHealth Technology TargEDys SA develops microbiome-based solutions for appetite regulation. It provides humanity with easy means of regulating their eating behaviors for the third millennium. The company was founded by Pierre Dechelotte and Gregory Lambert 2011 and is headquartered in Paris, France. | Health Technology |
Polaris SA /FR/
 Polaris SA /FR/ Pharmaceuticals: MajorHealth Technology Polaris SA engages in the biotechnology industry and specializes in the field of healthy omega 3 lipids. The company was founded by St?phane Lozachmeur and Gildas Breton on July 1, 1994 and is headquartered in Quimper, France. | Health Technology |
LiMM Therapeutics SA
LiMM Therapeutics SA Financial ConglomeratesFinance LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France. | Finance |
A-Mansia Biotech SA (Belgium)
A-Mansia Biotech SA (Belgium) Miscellaneous Commercial ServicesCommercial Services A-Mansia Biotech provides business services. The company was founded on October 11, 2016 and is headquartered in Ottignies-Louvain-la-Neuve, Belgium. | Commercial Services |
Iome Bio SA
Iome Bio SA Pharmaceuticals: OtherHealth Technology Iome Bio SA is a French company that provides drug discovery services using microbiome based mechanisms. The company is based in Colmar, France. Katharine Holland has been the CEO of the company since 2021. | Health Technology |
- Borsa valori
- Insiders
- Isabelle de Cremoux
